Cyclacel Pharmaceuticals Inc (CYCC) — Cash Flow-to-Debt Ratio
Cyclacel Pharmaceuticals Inc (CYCC) has a Cash Flow-to-Debt Ratio of -1.37x as of June 2025, meaning its operating cash flow of $-1.06K could theoretically repay -1% of its total liabilities ($770.00) in one year. See Cyclacel Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cyclacel Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for Cyclacel Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see how efficiently does Cyclacel Pharmaceuticals Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Cyclacel Pharmaceuticals Inc (2003–2024)
Year-by-year debt coverage analysis for Cyclacel Pharmaceuticals Inc. Check CYCC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.27x | $-7.99 Million | $6.27 Million | ▲ +35.1% |
| 2023 | -1.97x | $-16.11 Million | $8.20 Million | ▲ +28.1% |
| 2022 | -2.73x | $-20.83 Million | $7.62 Million | ▲ +19.7% |
| 2021 | -3.41x | $-18.54 Million | $5.44 Million | ▼ -52.1% |
| 2020 | -2.24x | $-7.93 Million | $3.54 Million | ▲ +14.4% |
| 2019 | -2.62x | $-9.45 Million | $3.61 Million | ▼ -77.7% |
| 2018 | -1.47x | $-6.70 Million | $4.55 Million | ▲ +16.6% |
| 2017 | -1.77x | $-7.48 Million | $4.24 Million | ▲ +5.6% |
| 2016 | -1.87x | $-10.08 Million | $5.39 Million | ▲ +23.3% |
| 2015 | -2.44x | $-14.46 Million | $5.93 Million | ▼ -0.4% |
| 2014 | -2.43x | $-18.70 Million | $7.70 Million | ▼ -0.1% |
| 2013 | -2.43x | $-18.20 Million | $7.50 Million | ▼ -88.2% |
| 2012 | -1.29x | $-12.04 Million | $9.34 Million | ▲ +40.0% |
| 2011 | -2.15x | $-13.98 Million | $6.50 Million | ▲ +12.4% |
| 2010 | -2.46x | $-16.04 Million | $6.54 Million | ▼ -58.7% |
| 2009 | -1.55x | $-15.19 Million | $9.82 Million | ▲ +46.6% |
| 2008 | -2.90x | $-29.91 Million | $10.31 Million | ▼ -124.8% |
| 2007 | -1.29x | $-23.14 Million | $17.94 Million | ▲ +40.2% |
| 2006 | -2.16x | $-20.17 Million | $9.36 Million | ▲ +31.4% |
| 2005 | -3.14x | $-21.51 Million | $6.84 Million | ▼ -71.2% |
| 2004 | -1.84x | $-21.09 Million | $11.48 Million | ▼ -888.2% |
| 2003 | -0.19x | $-15.49 Million | $83.34 Million | — |